Dishman Biotech Limited - Company Profile

Q: Who are the current directors of Dishman Biotech Limited?

The current directors of Dishman Biotech Limited are Deohooti Janmejay Vyas, Aditi Janmejay Vyas, Arpit Janmejay Vyas.

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1995.

1995 Ahmedabad, Gujarat, India Active

Last Updated: January 06, 2026

About Dishman Biotech Limited

Dishman Biotech Limited, a active public limited company, was established on 08 November 1995 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1995PLC028060. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹6.50 Cr.

Formerly known as Schutz Dishman Biotech Limited, Schutz Dishman Biotech Private Limited. It upholds a compliant status. Employing 17 professional, Its leadership includes Deohooti Janmejay Vyas (Director), Aditi Janmejay Vyas (Director), Arpit Janmejay Vyas (Director). Past directors included Rajnikant Thakorlal Vyas, Arpit Janmejay Vyas, Katrin Adelheid Tiemann. It holds ₹163.00 Cr open charges and ₹128.41 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dishman Corporate House, Iscon-Bopal Road, Ambli,, Ahmedabad, Gujarat, 380058.

Company Details

CIN/LLPIN
U24231GJ1995PLC028060
Registration Number
028060
Incorporation Date
08 November 1995
Authorized Capital
₹6.50 Cr
Paid-Up Capital
₹6.50 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 6.50 Cr as on 06-01-2026
Paid Up Capital ₹ 6.50 Cr as on 06-01-2026
Company Age 30 Year, 4 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 163.00 Cr as on 06-01-2026
Satisfied Charges ₹ 128.41 Cr as on 06-01-2026
Revenue Growth **** 4.32% (FY 2023)
Profit Growth **** -40.44% (FY 2023)
Ebitda **** 92.20% (FY 2023)
Net Worth 9.51% (FY 2023)
Total Assets **** 36.86% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Dishman Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Dishman Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Deohooti Janmejay Vyas	Director	01 Dec 1997	Current
Aditi Janmejay Vyas	Director	01 Dec 1997	Current
Arpit Janmejay Vyas	Director	03 Jun 2009	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	27 May 2009	Past
Pramod Abcsdd	Additional Director	30 Sep 2009	Past
Pramod Abcsdd	Director	01 Apr 2016	Past
Pramod Abcsdd	Director	01 Apr 2016	Past
Pramod Abcsdd	Director	01 Apr 2016	Past
Pramod Abcsdd	Director	27 May 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dishman Biotech.

Dishman Biotech Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.32% increase. The company also saw a substantial fall in profitability, with a 40.44% decrease in profit. The company's net worth moved up by a moderate rise of 9.51%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

4.32%

*******

Revenue from Operations

*******

-100.00%

*******

Total Assets

*******

36.86%

*******

Profit or Loss

*******

-40.44%

*******

Net Worth

*******

9.51%

*******

EBITDA

*******

92.20%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dishman Biotech?

In 2023, Dishman Biotech had a promoter holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,630,000,000.00

Satisfied Charges

₹1,284,100,000.00

Charges Breakdown by Lending Institutions

Others : 163.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Sep 2025	Others	₹75.00 Cr	Open
26 Aug 2025	Others	₹25.00 Cr	Open
31 Jul 2025	Others	₹15.00 Cr	Open
31 Dec 2024	Others	₹10.00 Cr	Open
01 Apr 2024	Others	₹38.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Dishman Biotech?

Dishman Biotech has a workforce of 17 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Dishman Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dishman Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dishman Biotech

Recent Activity within the Organization

Charges

Progress on A charge registered on 18 Feb 2020 via Charge ID 100330460 with Others was fully satisfied on 12 Nov 2025. was documented.
12 Nov 2025
Charges

The activity A charge registered on 18 Feb 2020 via Charge ID 100332685 with Others was fully satisfied on 12 Nov 2025. was completed.
12 Nov 2025
Charges

The activity A charge registered on 18 Feb 2020 via Charge ID 100330429 with Others was fully satisfied on 12 Nov 2025. was completed.
12 Nov 2025
Charges

The activity A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101165974 was registered on 30 Sep 2025. was completed.
30 Sep 2025
Charges

A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101147183 was registered on 26 Aug 2025. was recorded as a recent event.
26 Aug 2025
Charges

Progress on A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101150594 was registered on 31 Jul 2025. was documented.
31 Jul 2025

Explore recent activity and updates - View Recent Activity